M. Brennan

发表

Opioid abuse-deterrent strategies: role of clinicians in acute pain management

L. Webster, M. Brennan, L. Kwong, 2016, Postgraduate medicine.

Strategies to Optimize Pain Management With Opioids While Minimizing Risk of Abuse

S. Stanos, M. Brennan, 2010, PM & R : the journal of injury, function, and rehabilitation.

The clinical implications of cytochrome p450 interactions with opioids and strategies for pain management.

M. Brennan, 2012, Journal of pain and symptom management.

Prescription opioid abuse: challenges and opportunities for payers.

A. White, H. Birnbaum, R. Weiss, 2013, The American journal of managed care.

Patient-reported utilization patterns of fentanyl transdermal system and oxycodone hydrochloride controlled-release among patients with chronic nonmalignant pain.

M. Mordin, J. Reblando, J. Schein, 2003, Journal of managed care pharmacy : JMCP.

Summary of Short‐term and Long‐term Oxymorphone Efficacy (Pain) Studies in Low Back Pain, Cancer Pain, Osteoarthritis, and Neuropathic Pain

M. Brennan, 2009 .

Update on prescription extended-release opioids and appropriate patient selection

M. Brennan, 2013, Journal of multidisciplinary healthcare.

How effective is the addition of a corticosteroid compared to placebo for treatment of acute pharyngitis in children and adults?

M. Brennan, A. Little, 2019, Evidence-Based Practice.

OPIOIDS, SUBSTANCE ABUSE & ADDICTIONS SECTION Review Article Consensus Recommendations on Initiating Prescription Therapies for Opioid-Induced Constipation

M. Camilleri, L. Webster, A. Lembo, 2016 .

Consensus Recommendations on Initiating Prescription Therapies for Opioid‐Induced Constipation

M. Camilleri, L. Webster, A. Lembo, 2015, Pain medicine.

Prevalence and characteristics of breakthrough pain in opioid-treated patients with chronic noncancer pain.

R. Portenoy, M. Brennan, D. Bennett, 2006, The journal of pain : official journal of the American Pain Society.

Retrospective accounts of initial subjective effects of opioids in patients treated for pain who do or do not develop opioid addiction: a pilot case-control study.

D. Borsook, S. Butler, R. Weiss, 2008, Experimental and clinical psychopharmacology.

In vitro dissolution of calcium carbonate preparations

M. Brennan, L. Wartofsky, W. Duncan, 1991, Calcified Tissue International.

Do endovascular filters prevent PE as effectively as anticoagulants in patients with DVT?

M. Brennan, Sarah M Safranek, A. Flaim, 2010, The Journal of family practice.

Evidence-based oral transmucosal fentanyl citrate (OTFC) dosing guidelines.

G. Aronoff, M. Brennan, B. Ginsberg, 2005, Pain medicine.

The effect of opioid therapy on endocrine function.

M. Brennan, 2013, The American journal of medicine.

The Role of Urine Drug Testing for Patients on Opioid Therapy

J. Pergolizzi, Joseph W. Stauffer, M. Brennan, 2010, Pain practice : the official journal of World Institute of Pain.

Topical nonsteroidal anti-inflammatory drugs for the treatment of pain due to soft tissue injury: diclofenac epolamine topical patch

M. Brennan, D. Lionberger, 2010, Journal of pain research.

Efficacy of Valproate in Manic-Depressive Psychosis: Mechanism of Action and Implications for Pathophysiology

D. Borsook, M. Brennan, R. Sandyk, 1985 .

Changes in pain and concurrent pain medication use following compounded topical analgesic treatment for chronic pain: 3- and 6-month follow-up results from the prospective, observational Optimizing Patient Experience and Response to Topical Analgesics study

M. Brennan, J. Gudin, D. Dietze, 2017, Journal of pain research.

Prevalence and Characteristics of Breakthrough Pain in Opioid-Treated Patients With Chronic Noncancer Pain

R. Portenoy, M. Brennan, D. Bennett, 2006 .

The prescription opioid conundrum: 21st century solutions to a millennia-long problem

M. Brennan, J. Gudin, 2020, Postgraduate medicine.

Overview of treatment options and review of the current role and use of compression garments, intermittent pumps, and exercise in the management of lymphedema

M. Brennan, M J Brennan, L T Miller, 1998, Cancer.

Buprenorphine transdermal system and quality of life in opioid-experienced patients with chronic low back pain

A. Yarlas, M. Brennan, S. Ripa, 2013, Expert opinion on pharmacotherapy.

The comparative pharmacokinetics of physical manipulation by crushing of Xtampza® ER compared with OxyContin®.

E. Kopecky, M. Brennan, A. Fleming, 2017, Pain management.

Prevalence and characteristics of breakthrough pain in patients receiving opioids for chronic back pain in pain specialty clinics.

M. Brennan, D. Bennett, S. Simon, 2007, Journal of Opioid Management.

Do endovascular fi lters prevent PE as eff ectively as anti- coagulants in patients with DVT?

M. Brennan, Sarah M Safranek, A. Flaim, 2010 .

Sleep disturbances in patients with chronic pain: effectively managing opioid analgesia to improve outcomes

M. Brennan, J. Lieberman, 2009, Current medical research and opinion.

Sleep disturbances in patients with chronic pain: effectively managing opioid analgesia to improve outcomes.

M. Brennan, J. Lieberman, 2009, Current medical research and opinion.

Reduction of opioid use and improvement in chronic pain in opioid-experienced patients after topical analgesic treatment: an exploratory analysis

M. Brennan, J. Gudin, D. Dietze, 2018, Postgraduate medicine.

Patient-Reported Utilization Patterns of Fentanyl Transdermal System and Oxycodone Hydrochloride Controlled-Release Among Patients With Chronic Nonmalignant Pain

M. Mordin, J. Reblando, J. Schein, 2003, Journal of managed care pharmacy : JMCP.

Psychiatric consultation for women undergoing rehabilitation for upper-extremity lymphedema following breast cancer treatment.

J. Holland, S. Passik, M. Brennan, 1993, Journal of pain and symptom management.

Prescription opioid abuse: challenges and opportunities for payers.

H. Birnbaum, R. Weiss, B. Madras, 2013, The American journal of managed care.